FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2669811000001105: Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25770701000001113 Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25770801000001116 Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Is a Exemestane 25mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Is pack of Aromasin 25mg tablets (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has active ingredient Exemestane false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has AMP Aromasin 25mg tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Exemestane true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start